Atlas Trials

Identifying Predictors Of Response To Mepolizumab In CRSwNP

Clinical trial NCT05902325 · RECRUITING

Trial details

NCT number
NCT05902325
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Rhinosinusitis With Nasal Polyps
Start date
2023-10-03
Primary completion
2026-12-31
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.